发明名称 MEDICINE COMPRISING NK4 GENE OR RECOMBINANT NK4 GENE
摘要 <P>PROBLEM TO BE SOLVED: To provide a medicine effective for primary tumor of cancer, precisely, an NK4 gene medicine and recombinant NK4 gene protein preparation effective for the prophylaxis/therapy of the cancer and also effective against the metastasis of the cancer, more precisely, the NK4 gene medicine and recombinant NK4 gene protein preparation effective for the prophylaxis/therapy of the cancer metastasis, and further the medicine effective for the disease caused by vascularization including the cancer, more precisely the NK4 gene medicine and recombinant NK4 gene protein preparation effective for the disease caused by the vascularization. <P>SOLUTION: The medicine contains a DNA containing a base sequence represented by sequence number:1 or 2 or a DNA hybridizing with the DNA under a stringent condition. <P>COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008007514(A) 申请公布日期 2008.01.17
申请号 JP20070212194 申请日期 2007.08.16
申请人 KRINGLE PHARMA INC;NAKAMURA TOSHIICHI 发明人 NAKAMURA TOSHIICHI;MATSUMOTO KUNIO
分类号 A61K48/00;A61K9/127;A61K31/711;A61K35/76;A61K45/00;A61P35/00;A61P35/04;C12N15/09 主分类号 A61K48/00
代理机构 代理人
主权项
地址